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to minimize the acclimatization factor, an interval of at least one week was interposed between successive decompressions. For the intravenous glucose tolerance test, a test dose of 0.5 gm. of glucose/kg. of body weight was given. Blood samples were drawn immediately before the glucose was given, sometimes 15 minutes after injection, and in all cases at 30, 60, I 20 and 180 minutes after injection of the glucose. All blood sugar determinations were made by the method of Horvath and Hnehr (3) .
Blood lactic acid was determined by the method of Barker and Summerson (4) and the pyruvic acid by the method of Friedemann and Haugen (5) . The precautions recommended by Friedemann and Haugen were carefully followed in the obtaining and subsequent handling of the blood samples. In the studies made in the low-pressure chamber, a portable ice container was provided so that syringes might be cold at time of use, and the precipitated samples kept refrigerated until they were analyzed.
In the experiments in which adrenalin was given, it was administered by constant intravenous drip at a rate of 40 gamma per minute throughout the entire glucose tolerance test.
RESULTS
The experimental results obtained with regard to blood glucose, lactic acid and pyruvic acid levels, and the lactic acid-pyruvic acid relations under various conditions are shown in table I. The conditions under which the data were obtained are indicated in the table headings together with the experiment number. A standard glucose tolerance test equivalent of 24,000 was made a) at ground level (750 ft. above sea level), b) at the ft. altitude, 4 at ground level during a constant infusion of adrenalin, d) at ground level begun 15 minutes after cessation of 3 hours of a constant infusion of adrenalin, e) at the equivalent of 24,000 ft. altitude beginning one hour after the intraperitoneal injection of 2 cc/kg. of body weight of adrenal cortical extract, f> at ground level after the injection of the same amount of extract intraperitoneally, the last two receiving their cortical extract one hour before beginning the test, the first two beginning the test 15 minutes after, and the third immediately after the cortical extract was injected '9 and g) beginning immediately after a 3-hour exposure to simulated 24,000 feet. The remainder of the experiments were simulated tests where glucose was not injected to show the response of the animal, h) to altitude (24,000 feet) alone, i) to a continuous infusion of adrenalin at ground level, j> to adrenal cortical extract alone at altitude (24,000 feet), and K) Upjohn's Adrenal Cortex Extract alone at ground level.
Intravenotis Glucose Studies. The response of the dogs to the stress of intravenously administered glucose showed that (experimerzt 4, glucose tolerance test, the 3o-minute level of blood glucose was during at least the ordinary 55 mg. above the baseline in all cases and that values had returned to the baseline by 3 hours. Lactic and pyruvic acid levels showed no significant change.
The response to glucose (experiment 6), at altitude, in no case showed a 30. minute increment in blood glucose as high as the minimum increment for the test at ground level. Except in dog 4, with a very flat curve, the baseline values were never reached and two actually had begun to increase by the third hour. The lactic and pyruvic acid levels were elevated above those at ground level throughout the test, but no more than with exposure to altitude alone. When glucose was given (experiment 7) with an infusion of adrenalin, the baseline was elevated a variable amount and throughout the test the blood glucose was maintained well above a normal fasting level. The dogs beginning the test with the highest baseline blood glucose values showed the least increment after administration, thus indicating that the renal threshold played some part. Blood lactic and pyruvic acids tended to be very high in both arterial and venous samples but when arterial samples were used, the lactic acid-pyruvic acid ratios did not change much throughout the experiment.
The response to glucose (experiment S), after an infusion of adrenalin, showed the so-minute increment to be less than during an ordinary glucose tolerance test, and the baseline was usually increased. Return to the baseline blood glucose value was rapid, essentially within one hour. Lactic acid values were extremely low at the end of the experiment as was the lactic acid-pyruvic acid ratio.
The response to glucose (experiment z) at altitude, under the influence of adrenal cortical extract, showed that in the case of Eschatin2, the injected glucose disappeared from the bloodstream extremely rapidly (within 15 minutes). With the Vpjohn's extract, this was marked only in the case of dog 3, while dog 2 offered the only example that was less marked. It should be noted that the blood lactic and pyruvic acid were very high at the one-hour level, which was not the case during the ordinary glucose tolerance test. In general, all the blood lactic acid and pyruvic acid levels were increased when glucose was injected or when the blood glucose began to show a secondary rise. Dog 3 was interesting in that with both extracts it cleared its blood of glucose extremely rapidly with no secondary rise, but all with very high lactic and pyruvic acid levels. In all dogs, on being transferred from ground level to altitude, there was relatively little change in blood glucose.
The response to injected glucose at ground level under the influence of excess adrenal cortical extract (experiment 3) showed a low so-minute increment indicating rapid clearing of the blood of glucose. The blood glucose was then either maintained or increased, so at 3 hours the level was above a normal one in all cases. In the 2 dogs on which lactic and pyruvic acids were determined, there was increase of these at the s-hour levels.
The response to injected glucose (experiment 9), after exposure to 3 hours at 24,000 feet, was not markedly altered from that to glucose alone in two dogs studied.
Test Withozlt Injected Ghcose. Decompression to the equivalent of 24,000 feet (experiment lo> in only one case caused the blood glucose to go above a normal fasting level. All other cases, except one, exhibited blood glucose levels in the lower part of normal range immediately after the decompression. In all of these cases with relatively low blood glucose levels, the level gradually increased throughout the period of exposure while the two elevated ones decreased by so-minutes to a lower 2 Eschatin, an adrenal cortical extract, produced by Parke, Davis and Company. A constant infusion of adrenalin (experiment 11) maintained the blood glucose moderately above the baseline. Under adrenal cortical extract (experiment 4), decompression caused very little change in blood glucose level. Upjohn's Adrenal Cortex Extract (experiment 5) caused no rise in blood glucose level at the Is-minute period. In some cases, however, the r-hour level was moderately elevated. DISCUSSION The level of blood glucose at a given time in an animal is the sum total of a great number of factors which are so great that when the blood glucose level is changed, extreme care must be exercised to ascertain just what factors have been altered. One of these, decrease in oxygen tension, has been shown to be potent in bringing about changes in the level of blood glucose (6, 7) . However, there is little agreement as to its effect (6, 7); some report increase in the blood glucose levels (6, 7), some show no change, while still others show hypoglycemia. In addition to simply taking blood glucose levels, a great deal of additional information may at times be obtained by subjecting the animal to the stress of a suddenly added amount of glucose to find how it is utilized. This previously was done during exposure to simulated high altitudes and reported (I), but this in itself did not offer much in explanation of. the phenomena observed.
In the reaction: 2 reduced DPN3 + pyruvic acid ( lactic acid + 2 oxidized DPN, theoretically, the ratio of lactic acid to pyruvic acid will be determined by the ratio of reduced to oxidized DPN and therefore should reflect the level of oxygen in the tissues. This has been suggested by Friedemann and Haugen (9) who, under very carefully controlled conditions, did find small increases in humans in the lactic acid-pyruvic acid ratio at reduced atmospheric pressures.
In our experiments on dogs, we found that the same degree of significance could not be attached to the lactic acid and pyruvic acid values because of difficulty in keeping the animals quiet. This is brought out particularly when exposure to altitude alone (experiment IO) is studied. When venous samples were taken, there was extreme variation of both the lactic acid and pyruvic acid and lactate-pyruvate ratios throughout the test period. When arterial samples were taken, the results were much less variable but even then did not show levels significantly different from those at ground level.
At this point, it is interesting to note (experiment 7) the difference in results in taking venous or arterial samples when doing a glucose tolerance test and at the same time giving a constant infusion of adrenalin. Venous samples give extremely high and variable lactic acid and lactate-pyruvate ratios presumably because of the peripheral vasoconstriction and resultant stasis of the blood plus an increased glycolysis in the muscle tissue drained. The arterial samples, on the other hand, show fairly constant values for the lactate-pyruvic ratio, and the actual levels of the lactic and pyruvic acid values are what might be expected due to the added glucose and the glycolytic effect of adrenalin. Therefore, we have not taken credence in venous sample values but have accepted gross changes in values obtained from arterial samples. Subjecting animals acutely to reduced oxygen tension has been shown to cause an increased production of adrenalin with a resulting increase in blood sugar (7) . This effect of adrenalin occurs early; i.e., within 15 minutes after adrenalin is produced or injected. However, in our altitude experiments a gradual decompression was made to minimize the stimulation of the sympathico-adrenal system and on considering all studies at altitude, it is seldom seen that transferring the animals from the higher to the lower pressure caused an increase in the blood sugar. This is very much against the adrenal medulla playing any prominent r81e in the glucose tolerance at altitude. As can be seen from the fasting values, in all four cases where the standard glucose test was performed under decompression (experiment 6) the blood glucose was not elevated greatly by the decompression alone.
Consider now the remaining two effects together; namely, the effect of low oxygen tension on the various enzymes and the effect of adrenal cortical hormones. It has been shown in an associated study (IO) that adrenal cortical extract enhances glycogen formation from glucose. In fact, it can be seen from experiment 2, table I, that 0.5 gm. of glucose per kilogram of body weight is cleared from the bloodstream within 15 minutes. This does not rule out some smaller reduction of the action of enzymes due to lowered oxygen tension, but it is evident that at 24,000 feet, the enzymes responsible for glycogen formation from glucose are able to function rapidly and hormonal control plays much the pre-dominant r81e.
Furthermore, when the data are examined more carefully, one sees that the statement made in the previous paper (I) that the glucose tolerance of an animal during decompression is reduced is not the case. It will be noted that in no case was the go-minute increment in blood glucose, after intravenously injected glucose, as high when the test was made at 24,ooo feet as when it was made at ground level. This is also reported by Stickney, Northup and Van Liere (II) .
In other words, early in the test the glucose was actually taken from the blood stream more rapidly by the animal during hypoxia than when the corresponding test was done at ground level.
It has been shown that exposure to atmospheric decompression brings about stimulation of the adrenal glands with increased production of adrenal cortical hormones (12) . The effect of these hormones in bringing about gluconeogenesis from protein and fat is well known (8) . As can be noted from experiment 5, this gluconeogenic effect is evident in some cases one hour after injecting adrenal cortical extract while maximum effect has been shown to occur about the fourth hour after injection (13) . Therefore, the plausible explanation of the altered glucose tolerance test performed during atmospheric decompression is that increased amounts of cortical hormones are produced by the adrenal cortex. This results in a more rapid uptake of glucose and formation of glycogen in the early stages of the test, but later gluconeogenesis from protein and fat cause the blood glucose to be raised and the increased level is prolonged. This effect can be duplicated by giving adrenal cortical extract before a glucose tolerance test at ground level and the effects of altitude are accentuated by giving the extract. It is conceivable that if the gluconeogenic effect (14) in two human subjects. This could be, because after an animal is kept at altitude for some time, the gluconeogenic effect of adrenal cortical hormones is balanced and the blood glucose returns to more normal levels (12). However, the.glycogenic effect is apparently still active and Medvedeva (IS) has actually isolated a factor from adrenal cortical extract which has a glycogenic effect with no effect on protein catabolism. The blood glucose curve, after injected glucose at altitude or after injected adrenal cortical extract, varies from animal to animal depending upon individual variation in response to the glycogenic as opposed to the gluconeogenic effect of products of the adrenal cortex. For example; dog 3, in two tests done during atmospheric decompression after being given adrenal cortical extract, showed very little increase in his blood glucose level throughout the test even though markedly elevated lactic acid and pyruvic acid values indicated that gluconeogenesis was active. In this animal, apparently, the response to glycogenesis was more active in comparison to response to gluconeogenesis than was the case in the other animals observed. Should an animal be decompressed rapidly, excited, subjected to atmospheric decompression far beyond its tolerance or in any other way stimulated so that there is an increased production of adrenalin, then one would expect the glucose tolerance curve to be maintained at a higher level. This is probably true of dog I in experiment 6, and also of one of the dogs in the previous paper (I).
SUMMARY AND CONCLUSIONS
The effect of adrenalin under various conditions was studied and indications are that stimulation of the sympathico-adrenal system plays only a minor role in most cases where a glucose tolerance test is performed on dogs at a simulated altitude of 24,000 feet. Apparently, there is sufficient oxygen at this altitude to allow functioning of the enzymes involved in glucose metabolism so that actually there is more rapid formation of glycogen than at ground level. The factor playing the predominant role is an increased production from the adrenal cortex. Although there is delayed return of the blood glucose to the baseline level after injecting glucose at a simulated 24,000 feet, careful perusal of the data presented indicates there is actually an increase in glucose tolerance. The injected glucose is converted to glycogen early in the test more rapidly than at ground level and the high glucose levels thereafter are due to gluconeogenesis from fat and protein brought about by the increased production of hormones by the adrenal cortex. Adrenalin may play a minor role in certain cases where the blood glucose level is maintained at markedly increased levels.
